O'Connor P J, Rush W A, Peterson J, Morben P, Cherney L, Keogh C, Lasch S
HealthPartners, Minneapolis, Minn, USA. Patrick J. O'Connor@Health Partners.com
Arch Fam Med. 1996 Oct;5(9):502-6. doi: 10.1001/archfami.5.9.502.
To evaluate the impact of a continuous quality improvement (CQI) intervention on glycemic control of patients with diabetes mellitus attending a primary care clinic.
A CQI process designed by the Minnesota Department of Health to improve diabetes care was implemented at a volunteer clinic, with another similar clinic not using the CQI process assessed for comparison. Adults with diabetes were identified at both clinics using diagnostic and pharmacy databases. Glycosylated hemoglobin (HbA1c) values (reference range, 4.3%-6.1%) and out-patient utilization and charges were compared for all patients with diabetes at each clinic for the 12 months before and 18 months after initiation of the CQI intervention.
The mean HbA1c value at the intervention clinic fell from 8.9% at baseline to 8.4% at 12 months and to 7.9% at 18 months. The mean HbA1c value at the comparison clinic was 8.9% at baseline, 8.9% at 12 months, and 8.8% at 18 months (difference between clinics, t = 4.13, P < .001). Differences after the intervention in the proportion of patients at the comparison clinic (n = 121) vs the intervention clinic (n = 122) with HbA1c values of 8% or less (40% vs 51%), between 8% and 10% (33% vs 37%), and 10% or greater (27% vs 12%) were unlikely due to chance (chi 2 = 9.7, 2 df, P = .008). The intervention was not associated with increased utilization of outpatient visits or outpatient charges.
Involvement of nurses, physicians, and managers in a CQI process can improve patients' glycemic control in some health maintenance organization primary care settings, without increasing utilization or charges. Health maintenance organizations should consider CQI as one possible method to improve diabetes outcomes.
评估持续质量改进(CQI)干预措施对一家初级保健诊所糖尿病患者血糖控制的影响。
明尼苏达州卫生部设计的旨在改善糖尿病护理的CQI流程在一家志愿者诊所实施,同时评估另一家未采用CQI流程的类似诊所作为对照。通过诊断和药房数据库在两家诊所识别成年糖尿病患者。比较了CQI干预措施启动前12个月和启动后18个月每家诊所所有糖尿病患者的糖化血红蛋白(HbA1c)值(参考范围为4.3%-6.1%)、门诊利用率和费用。
干预诊所的平均HbA1c值从基线时的8.9%降至12个月时的8.4%,并在18个月时降至7.9%。对照诊所的平均HbA1c值在基线时为8.9%,12个月时为8.9%,18个月时为8.8%(诊所间差异,t = 4.13,P <.001)。干预后,对照诊所(n = 121)与干预诊所(n = 122)中HbA1c值小于或等于8%(40%对51%)、8%至10%(33%对37%)以及大于或等于10%(27%对12%)的患者比例差异不太可能是偶然因素导致的(χ² = 9.7,自由度为2,P =.008)。该干预措施与门诊就诊利用率或门诊费用的增加无关。
护士、医生和管理人员参与CQI流程可在一些健康维护组织初级保健机构中改善患者的血糖控制,且不会增加利用率或费用。健康维护组织应将CQI视为改善糖尿病治疗效果的一种可能方法。